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Background/Aims
Although mucosal mast cell tryptase is known to significantly increase intestinal permeability, the relationship between mucosal 
mast cells and intestinal permeability remains unclear. The objective of this study was to evaluate the correlation among in-
testinal permeability, tryptase activity and mucosal mast cell count.
Methods
Rectal biopsies from 16 patients with diarrhea-predominant irritable bowel syndrome (IBS-D) and 7 normal subjects were as-
sessed for tryptase activity and macromolecular permeability using horseradish peroxidase in Ussing chambers. In addition, mu-
cosal mast cell levels were immunohistochemically quantified via image analysis. 
Results
Rectal biopsy of tissues from IBS-D patients showed significantly increased permeability compared with those from normal con-
trols (0.644 ± 0.08 and 0.06 ± 0.00 ng/2 hr/mm2, P ＜ 0.01). Tryptase activity was also substantially higher in rectal biopsy 
samples from IBS-D patients than those from normal controls (0.86 ± 0.18 and 0.28 ± 0.04 mU/mg protein, P ＜ 0.05). 
Mucosal mast cell counts were not significantly different between the 2 groups (P ＞ 0.05). However, correlation analysis re-
vealed that only mucosal mast cell count was significantly correlated with intestinal permeability in IBS-D patients (r = 0.558, 
P ＜ 0.05).
Conclusions
This study demonstrated a positive correlation between the number of mucosal mast cells and intestinal permeability, suggest-
ing that mucosal mast cells play an important role for increased intestinal permeability in patients with IBS-D.
(J Neurogastroenterol Motil 2013;19:244-250)
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Introduction
Abnormal intestinal permeability has been implicated in the 
pathogenesis of many intestinal diseases, including irritable bowel 
syndrome (IBS). Symptoms of post-infectious IBS are associated 
with a subtle increase in intestinal permeability.1 Patients with di-
arrhea predominant IBS (IBS-D) have been shown to have in-
creased small intestinal permeability compared to post-infectious 
IBS patients and controls.2 These findings suggest that an abnor-
mal intestinal barrier facilitates enhanced antigen exposure that 
may activate the intestinal immune system and induce IBS symp-
toms such as abdominal pain.
Although the mechanism for increased intestinal perme-
ability in IBS is still unclear, mast cells seem to play an important 
role. Recent studies have demonstrated that chronic stress in-
creased the number and activity of mucosal mast cells and in-
duced mass cell-mediated alterations in epithelial function.3-5 
Furthermore, increased numbers of CD3, CD25 lymphocytes 
and mast cells have been detected in the colonic mucosa of IBS 
patients.6-8 Finally, it has been shown that IBS-D patients have 
increased rectal permeability responsive to mast cell tryptase.9
In our previous study,9 we demonstrated that mucosal mast 
cell tryptase plays an important role in the increased rectal perme-
ability in IBS. However, the relationship between mucosal mast 
cells and intestinal permeability remains unclear. Therefore, the 
goal of the present study is to evaluate the correlation among in-
testinal permeability, tryptase activity and mucosal mast cell 
count.
Materials and Methods
Subjects
Biopsy specimens of the rectum were obtained during routine 
colonoscopies of 16 patients with IBS-D and 7 healthy controls at 
the Kangbuk Samsung Hospital. All the IBS-D patients ex-
hibited symptoms that fulfilled the Rome-II criteria. Participants 
in the control group had macroscopically and histologically nor-
mal colonic mucosa, no persistent bowel symptoms, no organic or 
functional bowel disease, and no history of chronic medical 
disease. None of the IBS-D patients had known histories of ab-
dominal surgery, inflammatory bowel disease, or post-infectious 
IBS. Informed written consent was provided by all patients, and 
this study was approved by the hospital’s local ethics committee. 
Biopsy forceps with an opening diameter of 6 mm (FB-25K-1; 
Olympus, Tokyo, Japan) were used for the procedures. In most 
cases, 2 biopsies were taken from the rectum of IBS-D patients 
and controls.
Staining and Quantification of Mucosal Mast 
Cells
Staining for mucosal mast cells
Rectal mucosal mast cells were stained using a monoclonal 
antibody against the human mast cell protease tryptase. Biopsy 
specimens were fixed in 10% neutral buffered formalin for 24 
hours. For the immunohistochemistry, paraffin-embedded speci-
mens were cut with a microtome at 4 μm thickness. Just before 
staining, slides were deparaffinized in xylene and rehydrated in 
graded alcohol solutions. After dewaxing, tissue sections were in-
cubated with 0.5% hydrogen peroxide in methanol at 22°C for 10 
minutes and then washed with running tap water for 15 minutes. 
Sections were treated with 0.1% trypsin (Sigma, Poole, UK) 
mixed in 0.1% calcium chloride (pH 7.8) for 10 minutes at 37°C. 
Nonspecific binding of protein was blocked by incubation in nor-
mal rabbit serum diluted 1:5 in Tris-buffered saline (TBS; pH 
7.6) for 15 minutes. 
The slides were then incubated for 18 hours at 4°C with the 
monoclonal antibody AA1 (anti-human mast cell protease tryp-
tase; DAKO M7052, Dako Ltd., Cambridge, UK), washed in 
TBS for 7 minutes, and reincubated for 30 minutes with bio-
tinylated rabbit anti-mouse IgG (Amersham, Buckinghamshire, 
UK). After the slides were washed again in TBS for 7 minutes, 
finally they were incubated with streptavidin-biotin complex con-
jugated with horseradish peroxidase (HRP; DAKO k0377; 
Dako) for 30 minutes. 
The slides were developed in diaminobenzidine-hydrogen 
peroxide substrate (Sigma) for 10 minutes, and washed under 
running tap water for 5 minutes. Sections were then counter-
stained with hematoxylin followed by dehydration and clearance. 
And then they were mounted in DPX mountant (BDH Prolabo; 
VWR International Ltd., Leicestershire, UK).
Quantification of mucosal mast cells
Mucosal mast cells were counted under light microscopy at 
×400 magnification by an expert pathologist. Immunohisto-
chemically positive-stained mast cells were counted in five con-
secutive non-overlapping microscopic fields (3 sections × 2 bi-
opsy samples) with areas of 0.24 mm2. The pathologist did not 
know histological section’s group of origin.
Hyuk Lee, et al
246 Journal of Neurogastroenterology and Motility 
Figure 1. Comparison of intestinal permeability, tryptase activity and 
mucosal mast cell count between IBS-D patients (n = 16) and controls (n 
= 7). Intestinal permeability (A) and tryptase activity (B) of rectal biopsy 
tissues from IBS-D patients were significantly increased compared with 
biopsy tissues from normal controls. (C) However, mucosal mast cell 
counts were not significantly different between the 2 groups.
Measurement of Intestinal Permeability
The biopsy tissues were mounted in modified Ussing 
chambers. After mounting, each half chamber was filled with 2 
mL Krebs-Ringer bicarbonate (KRB) solution, bathing both the 
mucosal and serosal sides of the specimen. Both sides were gassed 
with 95% O2 and 5% CO2 and the temperature was kept at 37°C 
by heat block. After a 30-minute equilibration period, the KRB in 
the chamber of mucosal side was replaced with KRB containing 
HRP at a final concentration of 0.4 mg/mL, and the KRB on the 
serosal side was substituted for fresh KRB. A 0.3 mL sample was 
collected and replaced with 0.3 mL KRB on the serosal side every 
30 minutes, for a total of 120 minutes. Samples from the serosal 
chamber were analyzed enzymatically using a modified Wor-
thington method with o-dianisidine dihydrochloride (OPD; 
Sigma Chemical Co., St Louis, MO, USA) as the substrate. 
Samples of 50 μL were relocated to microtitre plates. Then, 100 
μL of OPD Working Solution (Stable Peroxide Buffer diluted 
1:10 in OPD solution) was transferred to each well, and the plate 
was incubated in a shaker at 300 rpm at room temperature. After 
30 minutes, 100 μL of 2.5 M sulfuric acid was applied, and 10 
minutes later, the absorbance of the discolorized reaction product 
was estimated at a wavelength of 490 nm using a microplate read-
er (Model 680; Bio-Rad Laboratories, Inc., Hercules, USA). 
All samples were run in duplicate and measured in reference to a 
standard curve. HRP flux was demonstrated as ng/2 hr/mm2 
during steady-state permeation in 30 minutes interval.
Tryptase Activity
Ten microliter of the supernatant from a tissue extract were 
applied to 200 μL of buffer (50 mmol/L Tris-HCl, pH 7.6; 120 
mmol/L NaCl; 20 g/L heparin) containing 0.5 mmol/L mast cell 
tryptase substrate (tosyl-glycine-proline-arginine-p-nitroanilide) 
and then they were incubated at room temperature for 17 hours. 
Substrate cleavage was measured using a microplate reader at an 
absorbance of 415 nm and normalized to the protein concen-
tration of the supernatant. Concentrations were measured auto-
matically against a standard curve. A specific mast cell tryptase 
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Figure 2. Correlation among mucosal mast cell count, tryptase 
activity and intestinal permeability in normal controls. There was no 
significant relationship between mucosal mast cell count and 
permeability (A), tryptase activity and mucosal mast cell count (B), 
and tryptase activity and permeability (C) (P ＞ 0.05, n = 7, 
respectively).
inhibitor (nafamostat mesilate) was used to confirm assay speci-
ficity.
Statistical Methods
All data are expressed as mean ± standard deviation (SD). 
Two-tailed Student’s t test was used for comparison of statistical 
differences in permeability, mucosal mast cell count and tryptase 
activity between normal subjects and IBS-D patients. Correla-
tions were analyzed by Pearson’s correlation. The alpha level of 
significance was set at P ＜ 0.05. All analyses were performed us-
ing SPSS (version 11.5.0; SPSS Inc., Chicago, IL, USA).
Results
Patient Characteristics
Sixteen patients with IBS-D (10 females, aged 24-66 years, 
mean 54.6 years) and 7 health controls (3 females, aged 38-64 
years, mean 49.0 years) were included. There was no significant 
difference in age and sex between 2 groups (P ＞ 0.05, re-
spectively). The median symptom duration was 65 months 
(range 7-360 months). 
Comparison of Intestinal Permeability, 
Tryptase Activity and Mucosal Mast Cell 
Count Between Diarrhea Predominant Irritable 
Bowel Syndrome Patients and Controls
Rectal biopsy samples from IBS-D patients showed sig-
nificantly increased permeability compared with those from nor-
mal controls (0.64 ± 0.08 and 0.06 ± 0.00 ng/2 hr/mm2, P ＜ 
0.01) (Fig. 1). Tryptase activity was also remarkably higher in 
rectal biopsy samples from IBS-D patients than those from nor-
mal controls (0.86 ± 0.18 and 0.28 ± 0.04 mU/mg protein, P < 
0.05). However, mucosal mast cell counts were not significantly 
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Figure 3. Correlation among intestinal permeability, mucosal mast 
cell count and tryptase activity. (A) A significant correlation was found 
between intestinal permeability and mucosal mast cell count (r = 
0.558, P ＜ 0.05). However, there were no notable relationships 
between intestinal permeability and tryptase activity (B) or mucosal 
mast cell count and tryptase activity (C) (P ＞ 0.05, n = 16, 
respectively).
different between the 2 groups (4.71 ± 0.60 and 4.66 ± 0.59 
number/0.24 mm2, P ＞ 0.05).
Correlation Among Mucosal Mast Cell Count, 
Tryptase Activity and Intestinal Permeability 
in Normal Controls
There was no remarkable relationship among intestinal per-
meability, tryptase activity and mucosal mast cell count in the 
control group (P ＞ 0.05) (Fig. 2).
Correlation Among Mucosal Mast Cell Count, 
Tryptase Activity and Intestinal Permeability 
in Diarrhea Predominant Irritable Bowel 
Syndrome Patients
A significant positive correlation between mucosal mast cell 
count and intestinal permeability was observed (r = 0.558, P ＜ 
0.05). However, there were no notable relationships between in-
testinal permeability and tryptase activity (r = -0.347, P ＞ 0.05) 
or mucosal mast cell count and tryptase activity (r = -0.448, P ＞ 
0.05) (Fig. 3).
Discussion
This study demonstrated that mucosal mast cell count is 
strongly associated with intestinal permeability. Even though 
there was no significant difference in mucosal mast cell count be-
tween IBS-D patients and normal controls, intestinal perme-
ability and tryptase activity were significantly higher in biopsy tis-
sues from IBS-D patients.
There is growing evidence that low grade mucosal in-
flammation plays an important role in the development of IBS,10 
with particular attention on mucosal mast cells. Several reports 
have suggested that IBS patients have a significantly increased 
number of mucosal mast cells compared with normal controls.6,11 
However, other studies have failed to show differences in mu-
cosal mast cell count between IBS patients and controls.12,13 In 
this study, the mucosal mast cell counts of IBS patients were sim-
ilar to those of normal controls, while intestinal permeability dif-
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fered between the 2 groups. These results are not consistent with 
our previous findings of both higher numbers of mucosal mast 
cells6 and increased permeability in IBS patients.9
Although small sample size and differences in symptom se-
verity between IBS-D patients could lead to inconsistent results, a 
possible explanation for this discrepancy in mucosal mast cell 
count and intestinal permeability between the 2 groups is that ac-
tivated mast cells may be associated with increased intestinal per-
meability rather than simply an increase in mucosal mast cell 
count. Compared to biopsy tissues from normal controls, those 
from IBS patients showed significantly higher tryptase activity, 
which is an indicator of mast cell activation in various disea-
ses.14,15 Therefore, despite having similar numbers of mucosal 
mast cells, the increased number of activated mast cells may in-
duce increased intestinal permeability in IBS patients. 
One interesting finding from this study was the positive cor-
relation between mucosal mast cell count and intestinal perme-
ability in IBS patients. In our earlier study, mucosal mast cell 
count was associated with visceral hypersensitivity in IBS-D 
patients.6 Similarly, other studies have reported that increased in-
testinal permeability in IBS patients may lead to IBS symptoms 
and visceral hypersensitivity.16,17 Taken together, these data and 
our results from the present study support the hypothesis that ac-
tivated mast cells may be responsible for the enhanced intestinal 
permeability and sensitivity observed in IBS patients.
Tryptase is the most abundant mediator stored in mast cell 
granules and has been used as a marker for mast cell activation.18 
Its activation of protease-activated receptor 2 (PAR-2) on enter-
ocytes causes changes in the organization of tight junction and 
permits the passage of macromolecules across the epithelial 
barrier.19,20 Although biopsy tissues from IBS patients in the 
present study exhibited high levels of tryptase activity and in-
creased permeability, tryptase activity did not correlate with in-
testinal permeability or mucosal mast cell count. This result likely 
indicates that enhanced tryptase activity is only partially respon-
sible for the increased permeability, and that other mast cell me-
diators or neural regulators may participate in the control of in-
testinal permeability.3,21 Further investigation is needed to identi-
fy and verify other mast cell factors that may control intestinal 
permeability.
In conclusion, rectal tissues from IBS-D patients showed in-
creased permeability and tryptase activity compared to those from 
normal controls. In addition, mucosal mast cell number positively 
correlated with intestinal permeability. These findings will be im-
portant in understanding the pathogenesis of increased intestinal 
permeability in IBS patients.
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